期刊
IUBMB LIFE
卷 61, 期 10, 页码 929-939出版社
WILEY
DOI: 10.1002/iub.239
关键词
transforming growth factor-beta (TGF beta); TGF beta receptors; Smads; canonical signaling; non-canonical signaling; carcinogenesis; cytostatic effects; epithelial to mesenchymal transition (EMT)
资金
- National Cancer Institute [CA55536, CA80095]
- American Heart Association [075080B]
- NATIONAL CANCER INSTITUTE [R01CA080095, R01CA055536, R29CA055536] Funding Source: NIH RePORTER
Transforming growth factor-beta (TGF beta) is a secreted cytokine, which intricately controls a plethora of physiological and pathological processes during development and carcinogenesis. TGF beta exerts antiproliferative effects and functions as a tumor suppressor during early stages of tumorigenesis, whereas at later stages it functions as a tumor promoter aiding in metastatic progression through an autocrine TGF beta loop. Intricate knowledge of TGF beta signaling and its regulation are still evolving. In this review, we make an attempt to showcase the associated enigma of TGF beta signaling in its dual functional role as tumor suppressor and metastatic promoter during early and late stages of carcinogenesis, respectively. (C) 2009 IUBMB IUBMB Life, 61(10): 929-939, 2009
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据